Copertina

In-Vitro Evaluation of ACTB Modulation: Implications for Biomarker Discovery, Drug Response Prediction, and Overcoming Chemoresistance in Breast Cancer Models

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Badhe, Pravin
Natura:	Recurso digital
Pubblicazione:	Zenodo 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Formulation Innovations Targeting ACTB Pathways in Breast Cancer: From Cytoskeletal Dysregulation to Precision Drug Delivery
di: Badhe, Ashwini
Pubblicazione: (2025)

From Bench to Biomarkers: RNA-seq-Driven Discovery of Chemoprevention Biomarkers in Animal Models
di: Badhe, Ashwini, et al.
Pubblicazione: (2026)

Clinical Relevance of EGFR in Breast Cancer: Precision Targeting for Better Outcomes
di: Badhe, Pravin
Pubblicazione: (2025)

RNA-seq–Based Mechanistic Evaluation of Phytochemicals and Small Molecules in Experimental Cancer Models
di: Badhe, Pravin, et al.
Pubblicazione: (2026)

In Vitro Validation of Herbal Products: Insights from MTT, ELISA, and Mechanistic Assays
di: Badhe, Pravin
Pubblicazione: (2025)

Pharma Marketing Management
di: Dr. Krishnananda Kamath K, Dr. Pravin Badhe, Tapan Kumar Mahato and Ashwini Badhe
Pubblicazione: (2025)

Glutathione‐Depletable Nanoinducer for Boosting Immunomodulatory Synergistic Therapy to Reverse Breast Cancer Chemoresistance
di: Senyi Gong, et al.
Pubblicazione: (2025)

Long-Tail Knowledge in Large Language Models: Taxonomy, Mechanisms, Interventions and Implications
di: Badhe, Sanket, et al.
Pubblicazione: (2026)

Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells
di: Chang‐Han Wu, et al.
Pubblicazione: (2025)

Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer
di: Minji Seo, et al.
Pubblicazione: (2026)

LegalSim: Multi-Agent Simulation of Legal Systems for Discovering Procedural Exploits
di: Badhe, Sanket
Pubblicazione: (2025)

ScamAgents: How AI Agents Can Simulate Human-Level Scam Calls
di: Badhe, Sanket
Pubblicazione: (2025)

Discovery of Capsazepine as a Novel MCL1 Inhibitor for Overcoming Tamoxifen Resistance in Breast Cancer Therapy
di: Shujing Liu, et al.
Pubblicazione: (2026)

Correction to “Terpenoids From Quinoa Reverse Chemoresistance in Breast Cancer by Suppressing the Stemness‐Related lncRNA 667012”
Pubblicazione: (2025)

Permeable Lung Vasculature Creates Chemoresistant Endothelial Niche by Producing SERPINE1 at Breast Cancer Metastatic Sites
di: Tsunaki Hongu, et al.
Pubblicazione: (2025)

Photodynamic Priming and Minocycline Overcome Chemoresistance by Reprogramming the Pancreatic Tumor Immune Microenvironment In Vivo
di: Fernanda V. Cabral, et al.
Pubblicazione: (2026)

Exosomes in the Chemoresistance of Glioma: Key Point in Chemoresistance
di: Xu Guo, et al.
Pubblicazione: (2025)

Evaluating the Diagnostic Potential of Biomarker Panels in Breast Cancer and Prostate Adenocarcinoma
di: Kldiashvili Ekaterina, et al.
Pubblicazione: (2025)

OGT‐Mediated O‐GlcNAcylation Stabilizes c‐Myc Activity and Promotes Chemoresistance in Triple‐Negative Breast Cancer
di: Jie Li, et al.
Pubblicazione: (2026)

A Novel “Three‐in‐One” Copper‐Based Metal‐Organic Framework Nanozyme Eradicates Colorectal Cancer and Overcomes Chemoresistance for Tumor Therapy
di: Shuohui Dong, et al.
Pubblicazione: (2024)

Prompt-Level Distillation: A Non-Parametric Alternative to Model Fine-Tuning for Efficient Reasoning
di: Badhe, Sanket, et al.
Pubblicazione: (2026)

Role Of Lipid Carriers in Overcoming Drug Resistance in Cancer
di: P. Sushma*, S. Varalaxmi
Pubblicazione: (2025)

Fabrication of Redox‐Responsive Macromolecular Prodrug Nanoparticles and Studies on Their In Vitro Therapeutic Efficacy of Breast Cancer
di: Yuxin Wang, et al.
Pubblicazione: (2025)

Targeting PKC as a Therapeutic Strategy to Overcome Chemoresistance in TNBC by Restoring Aurora Kinase B Expression
di: Bing Cheng, et al.
Pubblicazione: (2025)

NGR‐Modified CAF‐Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma
di: Jianxin Du, et al.
Pubblicazione: (2025)

Discordance Between Breast and Nodal Pathologic Response in Triple‐Negative Breast Cancer: Methodological Considerations and Contemporary Implications
di: Kadri Altundag
Pubblicazione: (2026)

Chemoresistance and Immune Suppression in Gastric Cancer Are Driven by PPDPF Overexpression
di: Chenqiang Pan, et al.
Pubblicazione: (2026)

A Novel PCD‐Driven Risk Model Predicts Prognosis and Chemoresistance in Gastric Cancer Through Tumor Microenvironment Deregulation
di: Xueying Wu, et al.
Pubblicazione: (2025)

Z‐Guggulsterone Induces Ferroptosis in Chemoresistant Breast Cancer via a CDKN2B ‐Mediated Suppression of GTP Cyclohydrolase 1
di: Zhuo‐Tao Yang, et al.
Pubblicazione: (2026)

The Use of FN‐Silk Networks as Extracellular Matrix‐Mimicking Support for 3D In Vitro Breast Cancer Models Improved the Model's Reproducibility in Drug Sensitivity
di: Suha Karrani, et al.
Pubblicazione: (2026)

Multi-modal Knowledge Decomposition based Online Distillation for Biomarker Prediction in Breast Cancer Histopathology
di: Zhang, Qibin, et al.
Pubblicazione: (2025)

Transfer RNA‐Derived Small RNAs: Novel Predictive Biomarkers for Diagnosis and Prognosis of Breast Cancer
di: Lihan Bie, et al.
Pubblicazione: (2026)

Quantum AI for Cancer Diagnostic Biomarker Discovery
di: Saggi, Mandeep Kaur, et al.
Pubblicazione: (2026)

Phytochemical‐Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics
di: Trupti Pratik Durgawale, et al.
Pubblicazione: (2025)

Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)
di: Andrew M. Riselli, et al.
Pubblicazione: (2025)

Targeting ERα Coregulator Networks to Overcome Endocrine Resistance in ER + Breast Cancer
di: Monika Bar, et al.
Pubblicazione: (2026)

The Identification of Novel Prognostic and Predictive Biomarkers in Breast Cancer via the Elucidation of Tumor Ecotypes Using Ecotyper
di: Feng Du, et al.
Pubblicazione: (2025)

A Novel “Three‐in‐One” Copper‐Based Metal‐Organic Framework Nanozyme Eradicates Colorectal Cancer and Overcomes Chemoresistance for Tumor Therapy (Adv. Sci. 6/2025)
di: Shuohui Dong, et al.
Pubblicazione: (2025)

Nanoinjection Platform for Drug Delivery in Breast Cancer Therapeutics
di: Kaviya Vijayalakshmi Babunagappan, et al.
Pubblicazione: (2025)

Clinical Relevance and Drug Modulation of PPAR Signaling Pathway in Triple‐Negative Breast Cancer: A Comprehensive Analysis
di: Yanxia Zhang, et al.
Pubblicazione: (2024)